Immune checkpoint inhibitors and EGFR-TKIs as adjuvant/neoadjuvant therapies for resectable non-small cell lung cancer a systematic review
The ESP Coordinating Center (ESP CC) is responding to a request from the VA National Oncology Program Office for a synthesis of evidence on the efficacy and safety of immune checkpoint inhibitors (ICIs) and epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) as adjuvant or neoadj...
| Main Authors: | , |
|---|---|
| Corporate Authors: | , |
| Format: | eBook |
| Language: | English |
| Published: |
Washington, DC
Department of Veterans Affairs, Veterans Health Administration, Health Services Research & Development Service
2023, April 2023
|
| Series: | Evidence synthesis program
|
| Online Access: | |
| Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
Table of Contents:
- Includes bibliographical references